European cancer centers restructure care in the era of COVID-19
Want to keep cancer patients and providers safe during the pandemic? Here’s how
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...
Cancer patients report delays in treatment because of COVID-19
Half of survey respondents in active treatment reported changes, delays, or disruptions to care.
Cancer care ‘transformed in space of a month’ because of pandemic
Changes brought about by COVID-19 may endure after the pandemic is over.
ASCO announces its own COVID-19 and cancer registry
ASCO aims to learn how COVID-19 is impacting cancer patients’ treatment and outcomes.
Cancer prevalence among COVID-19 patients may be higher than previously reported
A meta-analysis suggests the cancer prevalence among COVID-19 patients is 2%, not 1% as previously reported.
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
Conducting cancer trials amid the COVID-19 pandemic
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.
Maintaining cancer care in the face of COVID-19
Oncologists are moving cancer patients to other hospitals, reevaluating the need for cancer treatments, and embracing telemedicine to protect...